chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Rash, Vaccination site bruising, Vaccination site haemorrhage, Vaccination site pain
Clinical narrative: Red rash on her Pinkie; Could not move the Right Arm; Room Spinning if Lying Down (Dizziness); Nausea (Only when she feels Dizziness); Muscles in her face were moving in different directions; Burning Sensation at the Injection Site; Swollen Injection Site; Hot to touch Injection Site; Bruise Injection Site (Quarter Size); Prolonged Bleeding Injection Site; Severe Chills; Lack of Sleep; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Burning Sensation at the Injection Site), VACCINATION SITE SWELLING (Swollen Injection Site), VACCINATION SITE WARMTH (Hot to touch Injection Site), VACCINATION SITE BRUISING (Bruise Injection Site (Quarter Size)) and VACCINATION SITE HAEMORRHAGE (Prolonged Bleeding Injection Site) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included LEVOTHYROXINE, LIOTHYRONINE (NP THYROID), PROGESTERONE (PROGESTERON BESINS), ESTROGEN NOS and TESTOSTERONE for Menopause.    On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Mar-2021, the patient experienced VACCINATION SITE PAIN (Burning Sensation at the Injection Site), VACCINATION SITE SWELLING (Swollen Injection Site), VACCINATION SITE WARMTH (Hot to touch Injection Site), VACCINATION SITE BRUISING (Bruise Injection Site (Quarter Size)), VACCINATION SITE HAEMORRHAGE (Prolonged Bleeding Injection Site), CHILLS (Severe Chills), INSOMNIA (Lack of Sleep) and FEELING ABNORMAL (Muscles in her face were moving in different directions). On 14-Mar-2021, the patient experienced DYSKINESIA (Could not move the Right Arm), DIZZINESS (Room Spinning if Lying Down (Dizziness)) and NAUSEA (Nausea (Only when she feels Dizziness)). On 01-Apr-2021, the patient experienced RASH (Red rash on her Pinkie). On 13-Mar-2021, VACCINATION SITE PAIN (Burning Sensation at the Injection Site), VACCINATION SITE SWELLING (Swollen Injection Site), VACCINATION SITE WARMTH (Hot to touch Injection Site), VACCINATION SITE BRUISING (Bruise Injection Site (Quarter Size)), VACCINATION SITE HAEMORRHAGE (Prolonged Bleeding Injection Site), CHILLS (Severe Chills), INSOMNIA (Lack of Sleep) and FEELING ABNORMAL (Muscles in her face were moving in different directions) had resolved. On 03-Apr-2021, DYSKINESIA (Could not move the Right Arm) had resolved. At the time of the report, DIZZINESS (Room Spinning if Lying Down (Dizziness)), NAUSEA (Nausea (Only when she feels Dizziness)) and RASH (Red rash on her Pinkie) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information not provided.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling, Vaccination site warmth
Clinical narrative: Red rash on her Pinkie; Could not move the Right Arm; Room Spinning if Lying Down (Dizziness); Nausea (Only when she feels Dizziness); Muscles in her face were moving in different directions; Burning Sensation at the Injection Site; Swollen Injection Site; Hot to touch Injection Site; Bruise Injection Site (Quarter Size); Prolonged Bleeding Injection Site; Severe Chills; Lack of Sleep; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Burning Sensation at the Injection Site), VACCINATION SITE SWELLING (Swollen Injection Site), VACCINATION SITE WARMTH (Hot to touch Injection Site), VACCINATION SITE BRUISING (Bruise Injection Site (Quarter Size)) and VACCINATION SITE HAEMORRHAGE (Prolonged Bleeding Injection Site) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included LEVOTHYROXINE, LIOTHYRONINE (NP THYROID), PROGESTERONE (PROGESTERON BESINS), ESTROGEN NOS and TESTOSTERONE for Menopause.    On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Mar-2021, the patient experienced VACCINATION SITE PAIN (Burning Sensation at the Injection Site), VACCINATION SITE SWELLING (Swollen Injection Site), VACCINATION SITE WARMTH (Hot to touch Injection Site), VACCINATION SITE BRUISING (Bruise Injection Site (Quarter Size)), VACCINATION SITE HAEMORRHAGE (Prolonged Bleeding Injection Site), CHILLS (Severe Chills), INSOMNIA (Lack of Sleep) and FEELING ABNORMAL (Muscles in her face were moving in different directions). On 14-Mar-2021, the patient experienced DYSKINESIA (Could not move the Right Arm), DIZZINESS (Room Spinning if Lying Down (Dizziness)) and NAUSEA (Nausea (Only when she feels Dizziness)). On 01-Apr-2021, the patient experienced RASH (Red rash on her Pinkie). On 13-Mar-2021, VACCINATION SITE PAIN (Burning Sensation at the Injection Site), VACCINATION SITE SWELLING (Swollen Injection Site), VACCINATION SITE WARMTH (Hot to touch Injection Site), VACCINATION SITE BRUISING (Bruise Injection Site (Quarter Size)), VACCINATION SITE HAEMORRHAGE (Prolonged Bleeding Injection Site), CHILLS (Severe Chills), INSOMNIA (Lack of Sleep) and FEELING ABNORMAL (Muscles in her face were moving in different directions) had resolved. On 03-Apr-2021, DYSKINESIA (Could not move the Right Arm) had resolved. At the time of the report, DIZZINESS (Room Spinning if Lying Down (Dizziness)), NAUSEA (Nausea (Only when she feels Dizziness)) and RASH (Red rash on her Pinkie) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information not provided.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site warmth, Pain, Pruritus, Rash macular
Clinical narrative: A week ago, her arm started itching; it started getting warm; there is a little red spot; Her arm was sore for 3 days after getting 1st dose; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Her arm was sore for 3 days after getting 1st dose), PRURITUS (A week ago, her arm started itching), INJECTION SITE WARMTH (it started getting warm) and RASH MACULAR (there is a little red spot) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included ESTRADIOL and CABERGOLINE for an unknown indication.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Mar-2021, the patient experienced PAIN (Her arm was sore for 3 days after getting 1st dose). On 30-Mar-2021, the patient experienced PRURITUS (A week ago, her arm started itching), INJECTION SITE WARMTH (it started getting warm) and RASH MACULAR (there is a little red spot). The patient was treated with HYDROCORTISONE at an unspecified dose and frequency. At the time of the report, PAIN (Her arm was sore for 3 days after getting 1st dose), INJECTION SITE WARMTH (it started getting warm) and RASH MACULAR (there is a little red spot) outcome was unknown and PRURITUS (A week ago, her arm started itching) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.; Sender's Comments
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Nausea, Vaccination site erythema, Vaccination site swelling
Clinical narrative: Circular redness around site; Minimal swelling; Chills; Nausea; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills), NAUSEA (Nausea), FATIGUE (Fatigue), VACCINATION SITE ERYTHEMA (Circular redness around site) and VACCINATION SITE SWELLING (Minimal swelling) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010A21A and 017B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Apr-2021, the patient experienced CHILLS (Chills), NAUSEA (Nausea) and FATIGUE (Fatigue). On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (Circular redness around site) and VACCINATION SITE SWELLING (Minimal swelling). On 04-Apr-2021, CHILLS (Chills), NAUSEA (Nausea) and FATIGUE (Fatigue) had resolved. At the time of the report, VACCINATION SITE ERYTHEMA (Circular redness around site) and VACCINATION SITE SWELLING (Minimal swelling) outcome was unknown.            No relevant concomitant product use was reported.  No treatment details were provided   This case was linked to US-MODERNATX, INC.-MOD-2021-068557 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-068557:
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: missed his second dose; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (missed his second dose) in an 84-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (missed his second dose). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (missed his second dose) outcome was unknown. Not Provided          Concomitant medications taken by the patient were not provided. Treatment information was not provided.  Action taken with mRNA-1273 in response to the event was not applicable.   This case was linked to US-MODERNATX, INC.-MOD-2021-068589 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-068589:Wife case
Age: 16.0
Sex: U
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: patient aged 16 years of age received a first dose; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (patient aged 16 years of age received a first dose) in a 16-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 021B21A and 004C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 29-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 02-Apr-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (patient aged 16 years of age received a first dose). On 02-Apr-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (patient aged 16 years of age received a first dose) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The patient stayed in the pharmacy for 15 minutes after receiving the vaccine and left afterwards.  No adverse events were reported. No concomitant medications were reported. No treatment information was provided by the reporter.   This case was linked to MOD-2021-225670 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 02-Apr-2021: The follow up document contains NO NEW INFORMATION. On 17-Jun-2021: Follow-up information received on 17-Jun-2021: Second dose added. Updated race and ethnic.; Sender's Comments: This report refers to a case of product administered to patient of inappropriate age (16 year old) for mRNA-1273 (lot number-021B21A) with no associated AEs reported.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Muscle twitching, Pain in extremity, Pruritus, Vaccination site warmth
Clinical narrative: arm was red; hot to touch; itchy; soreness in arm; twitching in leg; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (soreness in arm), MUSCLE TWITCHING (twitching in leg), ERYTHEMA (arm was red), VACCINATION SITE WARMTH (hot to touch) and PRURITUS (itchy) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Mar-2021, the patient experienced PAIN IN EXTREMITY (soreness in arm) and MUSCLE TWITCHING (twitching in leg). On 06-Apr-2021, the patient experienced ERYTHEMA (arm was red), VACCINATION SITE WARMTH (hot to touch) and PRURITUS (itchy). On 31-Mar-2021, PAIN IN EXTREMITY (soreness in arm) and MUSCLE TWITCHING (twitching in leg) had resolved. At the time of the report, ERYTHEMA (arm was red), VACCINATION SITE WARMTH (hot to touch) and PRURITUS (itchy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       concomitant medications  were not reported  Treatment was not specified
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: shingles; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (shingles) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001b21a) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Mar-2021, the patient experienced HERPES ZOSTER (shingles). At the time of the report, HERPES ZOSTER (shingles) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medication was not provided.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal discomfort, Bed rest, Hiccups, Vomiting
Clinical narrative: upset stomach; stomach feels terrible; hiccups; vomited in the morning; been flat on his back in bed; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISCOMFORT (upset stomach), ABDOMINAL DISCOMFORT (stomach feels terrible), HICCUPS (hiccups), BED REST (been flat on his back in bed) and VOMITING (vomited in the morning) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046A21A) for COVID-19 vaccination.     Concomitant products included LEVOTHYROXINE, INSULIN, CARVEDILOL, FAMOTIDINE, VITAMINS NOS, POTASSIUM, PRAVASTATIN, MONTELUKAST and FUROSEMIDE for an unknown indication.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, the patient experienced BED REST (been flat on his back in bed). On 04-Apr-2021, the patient experienced ABDOMINAL DISCOMFORT (upset stomach), ABDOMINAL DISCOMFORT (stomach feels terrible), HICCUPS (hiccups) and VOMITING (vomited in the morning). At the time of the report, ABDOMINAL DISCOMFORT (upset stomach), ABDOMINAL DISCOMFORT (stomach feels terrible), HICCUPS (hiccups), BED REST (been flat on his back in bed) and VOMITING (vomited in the morning) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       treatment medication includes Tums
Sex: F
Vaccine: COVID19
Symptoms: Local reaction, Vaccination site erythema, Vaccination site swelling
Clinical narrative: Local reaction; Redness on the injection site; Swelling on the injection site; This spontaneous case was reported by a health care professional and describes the occurrence of LOCAL REACTION (Local reaction), VACCINATION SITE ERYTHEMA (Redness on the injection site) and VACCINATION SITE SWELLING (Swelling on the injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 04-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced LOCAL REACTION (Local reaction), VACCINATION SITE ERYTHEMA (Redness on the injection site) and VACCINATION SITE SWELLING (Swelling on the injection site). At the time of the report, LOCAL REACTION (Local reaction), VACCINATION SITE ERYTHEMA (Redness on the injection site) and VACCINATION SITE SWELLING (Swelling on the injection site) was resolving.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications reported by investigator  No treatment medications provided by the reporter.  Patient stated that symptoms lasted for 3-4 days then got better and also reported of taking antihistamines for allergy   This case was linked to US-MODERNATX, INC.-MOD-2021-068997, US-MODERNATX, INC.-MOD-2021-008799 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-068997:1st dose US-MODERNATX, INC.-MOD-2021-008799:
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Tachycardia, Vertigo
Clinical narrative: Vertigo was coming back when she was watching TV; Heart was racing; Felt terrible like I was going to die,She stated it felt severe and came out of nowhere, She could only lay on her right side; This spontaneous case was reported by a consumer and describes the occurrence of VERTIGO (Vertigo was coming back when she was watching TV), TACHYCARDIA (Heart was racing) and FEELING ABNORMAL (Felt terrible like I was going to die,She stated it felt severe and came out of nowhere, She could only lay on her right side) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Apr-2021, the patient experienced VERTIGO (Vertigo was coming back when she was watching TV), TACHYCARDIA (Heart was racing) and FEELING ABNORMAL (Felt terrible like I was going to die,She stated it felt severe and came out of nowhere, She could only lay on her right side). The patient was treated with VITAMIN C [ASCORBIC ACID] at a dose of 500 milligram and IBUPROFEN at a dose of Two ibuprofens. At the time of the report, VERTIGO (Vertigo was coming back when she was watching TV), TACHYCARDIA (Heart was racing) and FEELING ABNORMAL (Felt terrible like I was going to die,She stated it felt severe and came out of nowhere, She could only lay on her right side) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications was provided.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Lymphadenopathy, Myalgia, Throat irritation, Vaccination site pain
Clinical narrative: frog in throat like a tickle; pain and tenderness at injection site; pain and tenderness at injection site; Swollen glands; Muscle pain in back; Tired; This spontaneous case was reported by a consumer and describes the occurrence of THROAT IRRITATION (frog in throat like a tickle), the first episode of VACCINATION SITE PAIN (pain and tenderness at injection site), the second episode of VACCINATION SITE PAIN (pain and tenderness at injection site), LYMPHADENOPATHY (Swollen glands) and MYALGIA (Muscle pain in back) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced THROAT IRRITATION (frog in throat like a tickle), the first episode of VACCINATION SITE PAIN (pain and tenderness at injection site), the second episode of VACCINATION SITE PAIN (pain and tenderness at injection site), LYMPHADENOPATHY (Swollen glands), MYALGIA (Muscle pain in back) and FATIGUE (Tired). At the time of the report, THROAT IRRITATION (frog in throat like a tickle), the last episode of VACCINATION SITE PAIN (pain and tenderness at injection site), LYMPHADENOPATHY (Swollen glands), MYALGIA (Muscle pain in back) and FATIGUE (Tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant and treatment medications were reported
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: Brief periods of lightheadedness; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Brief periods of lightheadedness) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Thalassemia minor since 28-Jan-1948. Concomitant products included METOPROLOL SUCCINATE from 21-Feb-2021 to an unknown date for Atrial fibrillation, LOSARTAN and HYDROCHLOROTHIAZIDE for Blood pressure management, MULTIVITAMIN [VITAMINS NOS], THIAMINE HYDROCHLORIDE (VITAMIN B-1), COLECALCIFEROL (D-3) and FOLIC ACID for an unknown indication.   On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 12-Mar-2021, the patient experienced DIZZINESS (Brief periods of lightheadedness). At the time of the report, DIZZINESS (Brief periods of lightheadedness) outcome was unknown.            No treatment information were reported.   This case was linked to MOD-2021-019032 (Patient Link).
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site induration, Rash erythematous, Vaccination site rash
Clinical narrative: Rash that was red; Bump/pimple at injection site; Rash is round and raised; This spontaneous case was reported by a consumer and describes the occurrence of RASH ERYTHEMATOUS (Rash that was red), INJECTION SITE INDURATION (Bump/pimple at injection site) and VACCINATION SITE RASH (Rash is round and raised) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032B21A and 030A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 31-Mar-2021, the patient experienced RASH ERYTHEMATOUS (Rash that was red), INJECTION SITE INDURATION (Bump/pimple at injection site) and VACCINATION SITE RASH (Rash is round and raised). At the time of the report, RASH ERYTHEMATOUS (Rash that was red), INJECTION SITE INDURATION (Bump/pimple at injection site) and VACCINATION SITE RASH (Rash is round and raised) had resolved.            No relevant concomitant medications were reported.  No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 26-Jun-2021: Follow-up information received on 26-JUN-2021. Updated outcome of all the events(From unknown to recovered/resolved),
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site swelling, Vaccination site warmth
Clinical narrative: patient's arm from the injection site was hot/very warm/5-6 inches that was red and warm to touch; patient's arm from the injection site was swollen; patient's arm from the injection site was really red/ redness was spreading around the area from a size of an Oreo cookie to very large/5-6 inches that was red; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (patient's arm from the injection site was hot/very warm/5-6 inches that was red and warm to touch), VACCINATION SITE SWELLING (patient's arm from the injection site was swollen) and VACCINATION SITE ERYTHEMA (patient's arm from the injection site was really red/ redness was spreading around the area from a size of an Oreo cookie to very large/5-6 inches that was red) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-Apr-2021, the patient experienced VACCINATION SITE WARMTH (patient's arm from the injection site was hot/very warm/5-6 inches that was red and warm to touch), VACCINATION SITE SWELLING (patient's arm from the injection site was swollen) and VACCINATION SITE ERYTHEMA (patient's arm from the injection site was really red/ redness was spreading around the area from a size of an Oreo cookie to very large/5-6 inches that was red). At the time of the report, VACCINATION SITE WARMTH (patient's arm from the injection site was hot/very warm/5-6 inches that was red and warm to touch), VACCINATION SITE SWELLING (patient's arm from the injection site was swollen) and VACCINATION SITE ERYTHEMA (patient's arm from the injection site was really red/ redness was spreading around the area from a size of an Oreo cookie to very large/5-6 inches that was red) outcome was unknown.            Concomitant product use was not provided by the reporter. Treatment medication included an antibiotic cream on the injection site on 06 Apr 2021 and some cold ice. Action taken with mRNA-1273 in response to events were not applicable.
Age: 16.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: injection to pediatric patient; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (injection to pediatric patient) in a 16-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21B) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (injection to pediatric patient). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (injection to pediatric patient) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   In events they reported as updated contact information. No concomitant medication were provided. No treatment details were provided.   Most recent FOLLOW-UP information incorporated above includes: On 13-Jul-2021: fallow up received , updated contact information
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Eye irritation, Fatigue, Pyrexia, Vaccination site pain
Clinical narrative: eyes burning; Low grade fever 99.1 degrees F; fatigue; soreness at injection site; This spontaneous case was reported by a consumer and describes the occurrence of EYE IRRITATION (eyes burning), VACCINATION SITE PAIN (soreness at injection site), PYREXIA (Low grade fever 99.1 degrees F) and FATIGUE (fatigue) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 from 21-Mar-2021 to 31-Mar-2021. Concomitant products included LISDEXAMFETAMINE MESILATE (VYVANSE) and VENLAFAXINE HYDROCHLORIDE (EFFEXOR) for an unknown indication.    On 05-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Apr-2021, the patient experienced VACCINATION SITE PAIN (soreness at injection site) and FATIGUE (fatigue). On 06-Apr-2021, the patient experienced EYE IRRITATION (eyes burning) and PYREXIA (Low grade fever 99.1 degrees F). At the time of the report, EYE IRRITATION (eyes burning), VACCINATION SITE PAIN (soreness at injection site), PYREXIA (Low grade fever 99.1 degrees F) and FATIGUE (fatigue) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 06-Apr-2021, Body temperature: 99.1 degrees f (Low) 99.1 degrees F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment medications was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Heart rate increased, Vertigo
Clinical narrative: her own adverse reaction following her first dose of Moderna COVID19 Vaccine; heart was racing; felt terrible like I was going to die; This spontaneous case was reported by a consumer and describes the occurrence of VERTIGO (her own adverse reaction following her first dose of Moderna COVID19 Vaccine), HEART RATE INCREASED (heart was racing) and FEELING ABNORMAL (felt terrible like I was going to die) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VERTIGO (her own adverse reaction following her first dose of Moderna COVID19 Vaccine), HEART RATE INCREASED (heart was racing) and FEELING ABNORMAL (felt terrible like I was going to die). At the time of the report, VERTIGO (her own adverse reaction following her first dose of Moderna COVID19 Vaccine), HEART RATE INCREASED (heart was racing) and FEELING ABNORMAL (felt terrible like I was going to die) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Sex: U
Vaccine: COVID19
Symptoms: Device connection issue, Underdose
Clinical narrative: This was my second shot, some of it was outside my arm; This was my second shot, some of it was outside my arm; This spontaneous case was reported by an other and describes the occurrence of UNDERDOSE (This was my second shot, some of it was outside my arm) and DEVICE CONNECTION ISSUE (This was my second shot, some of it was outside my arm) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced UNDERDOSE (This was my second shot, some of it was outside my arm) and DEVICE CONNECTION ISSUE (This was my second shot, some of it was outside my arm). At the time of the report, UNDERDOSE (This was my second shot, some of it was outside my arm) and DEVICE CONNECTION ISSUE (This was my second shot, some of it was outside my arm) had resolved.            The action taken with mRNA-1273(Moderna COVID-19 vaccine) was not applicable  No concomitant medications were reported  No treatment drugs were reported   Most recent FOLLOW-UP information incorporated above includes: On 16-Jun-2021: Follow up document received 16-jun-2021 has No New Information.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Headache, Myalgia
Clinical narrative: joint pain; muscle ache; headache; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (joint pain), MYALGIA (muscle ache) and HEADACHE (headache) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038a21a) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Apr-2021, the patient experienced ARTHRALGIA (joint pain), MYALGIA (muscle ache) and HEADACHE (headache). At the time of the report, ARTHRALGIA (joint pain), MYALGIA (muscle ache) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment medication was reported.   Reporter did not allow further contact
Sex: U
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: Vaccination adverse reaction; This spontaneous case was reported by an other and describes the occurrence of VACCINATION COMPLICATION (Vaccination adverse reaction) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Vaccination adverse reaction). At the time of the report, VACCINATION COMPLICATION (Vaccination adverse reaction) outcome was unknown.            Treatment medications were not provided.  Concomitant medications were not reported.  The action taken with mRNA-1273(Moderna COVID-19 vaccine) was not applicable
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: sore arm after first dose; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 06-Apr-2021 and was forwarded to Moderna on 06-Apr-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm after first dose) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013A21A and 026B21A) for COVID-19 vaccination.     Concomitant products included ASPIRIN [ACETYLSALICYLIC ACID] and MULTIVITAMIN [VITAMINS NOS] for an unknown indication.   On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Mar-2021, the patient experienced PAIN IN EXTREMITY (sore arm after first dose). At the time of the report, PAIN IN EXTREMITY (sore arm after first dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       concomitant  medicines include low dose aspirin, multivitamin, B12 shot once a month.   This case was linked to US-MODERNATX, INC.-MOD-2021-069278 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-069278:2nd dose
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Anaemia vitamin B12 deficiency, Chills, Dizziness, Headache, Myalgia
Clinical narrative: Dizziness; "Tender headaches; Chills; Body aches; Patient due for B12 injection this month; Sore arm after second dose; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm after second dose), ANAEMIA VITAMIN B12 DEFICIENCY (Patient due for B12 injection this month), DIZZINESS (Dizziness), HEADACHE ("Tender headaches) and CHILLS (Chills) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026B21A and 013A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included MECOBALAMIN (B12 RAPID SHOT), ACETYLSALICYLIC ACID (ASPIRIN KENT [ACETYLSALICYLIC ACID]) and MULTIVITAMIN [VITAMINS NOS] for an unknown indication.   On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 31-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PAIN IN EXTREMITY (Sore arm after second dose). On 01-Apr-2021, the patient experienced DIZZINESS (Dizziness), HEADACHE ("Tender headaches), CHILLS (Chills) and MYALGIA (Body aches). In April 2021, the patient experienced ANAEMIA VITAMIN B12 DEFICIENCY (Patient due for B12 injection this month). At the time of the report, PAIN IN EXTREMITY (Sore arm after second dose), ANAEMIA VITAMIN B12 DEFICIENCY (Patient due for B12 injection this month), DIZZINESS (Dizziness), HEADACHE ("Tender headaches), CHILLS (Chills) and MYALGIA (Body aches) outcome was unknown.            Concomitant medicines include low dose aspirin, multivitamin, B12 shot once a month. Treatment included pain reliever, acetaminophen.   This case was linked to US-MODERNATX, INC.-MOD-2021-069267 (E2B Linked Report). This case was linked to MOD-2021-069267 (Patient Link).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-069267:2nd dose
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Dizziness; "Tender headaches; Chills; Body aches; Patient due for B12 injection this month; Sore arm after second dose; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm after second dose), ANAEMIA VITAMIN B12 DEFICIENCY (Patient due for B12 injection this month), DIZZINESS (Dizziness), HEADACHE ("Tender headaches) and CHILLS (Chills) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026B21A and 013A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included MECOBALAMIN (B12 RAPID SHOT), ACETYLSALICYLIC ACID (ASPIRIN KENT [ACETYLSALICYLIC ACID]) and MULTIVITAMIN [VITAMINS NOS] for an unknown indication.   On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 31-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PAIN IN EXTREMITY (Sore arm after second dose). On 01-Apr-2021, the patient experienced DIZZINESS (Dizziness), HEADACHE ("Tender headaches), CHILLS (Chills) and MYALGIA (Body aches). In April 2021, the patient experienced ANAEMIA VITAMIN B12 DEFICIENCY (Patient due for B12 injection this month). At the time of the report, PAIN IN EXTREMITY (Sore arm after second dose), ANAEMIA VITAMIN B12 DEFICIENCY (Patient due for B12 injection this month), DIZZINESS (Dizziness), HEADACHE ("Tender headaches), CHILLS (Chills) and MYALGIA (Body aches) outcome was unknown.            Concomitant medicines include low dose aspirin, multivitamin, B12 shot once a month. Treatment included pain reliever, acetaminophen.   This case was linked to US-MODERNATX, INC.-MOD-2021-069267 (E2B Linked Report). This case was linked to MOD-2021-069267 (Patient Link).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-069267:2nd dose
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Lymph node pain, Lymphadenopathy
Clinical narrative: swollen, hard and sore lymph nodes in the neck; swollen, hard and sore lymph nodes in the neck; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (swollen, hard and sore lymph nodes in the neck) and LYMPH NODE PAIN (swollen, hard and sore lymph nodes in the neck) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported. ).    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Apr-2021, the patient experienced LYMPHADENOPATHY (swollen, hard and sore lymph nodes in the neck) and LYMPH NODE PAIN (swollen, hard and sore lymph nodes in the neck). At the time of the report, LYMPHADENOPATHY (swollen, hard and sore lymph nodes in the neck) and LYMPH NODE PAIN (swollen, hard and sore lymph nodes in the neck) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant products were not provided.   Treatment products were not provided.  Based on current available information and the temporal relationship between product use and the start date of the events a causal relationship cannot be excluded.  Lymphadenopathy is not and IME, not Medically Significant and Non-serious   Reporter did not allow further contact; Sender's Comments: Based on current available information and the temporal relationship between product use and the start date of the events a causal relationship cannot be excluded.
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Induration, Lymphadenopathy, Swelling, Tenderness
Clinical narrative: Swoolen right arm and shoulder; Tenderness and hardness over right shoulder; Hardness over right shoulder; Swollen lymph nodes on right side; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (Swoolen right arm and shoulder), TENDERNESS (Tenderness and hardness over right shoulder), INDURATION (Hardness over right shoulder) and LYMPHADENOPATHY (Swollen lymph nodes on right side) in a 41-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Mar-2021, the patient experienced SWELLING (Swoolen right arm and shoulder), TENDERNESS (Tenderness and hardness over right shoulder), INDURATION (Hardness over right shoulder) and LYMPHADENOPATHY (Swollen lymph nodes on right side). At the time of the report, SWELLING (Swoolen right arm and shoulder), TENDERNESS (Tenderness and hardness over right shoulder), INDURATION (Hardness over right shoulder) and LYMPHADENOPATHY (Swollen lymph nodes on right side) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       At the time of this report, symptoms were still ongoing. Patient was taking blood pressure pills as concomitant medications.   Treatment information was not provided.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Arthralgia, Asthenia, Cough, Decreased appetite
Clinical narrative: extremely weak; nausea; severe headache that comes and goes; joint pain; Tiredness; dizzy; very sick, and . Also has and . Onff c and oough; very sick, and . Also has and . Onff c and oough; no appetite; could not taste anything; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizzy), ILLNESS (very sick, and . Also has and . Onff c and oough), COUGH (very sick, and . Also has and . Onff c and oough), DECREASED APPETITE (no appetite) and AGEUSIA (could not taste anything) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included LISINOPRIL for an unknown indication.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Mar-2021, the patient experienced DIZZINESS (dizzy), ILLNESS (very sick, and . Also has and . Onff c and oough), COUGH (very sick, and . Also has and . Onff c and oough), DECREASED APPETITE (no appetite), AGEUSIA (could not taste anything), ASTHENIA (extremely weak), NAUSEA (nausea), HEADACHE (severe headache that comes and goes), ARTHRALGIA (joint pain) and FATIGUE (Tiredness). The patient was treated with PARACETAMOL (TYLENOL) for Headache and Joint pain, at an unspecified dose and frequency and NAPROXEN SODIUM (ALEVE) at an unspecified dose and frequency. At the time of the report, DIZZINESS (dizzy), ILLNESS (very sick, and . Also has and . Onff c and oough), COUGH (very sick, and . Also has and . Onff c and oough), DECREASED APPETITE (no appetite), AGEUSIA (could not taste anything), ASTHENIA (extremely weak), NAUSEA (nausea), HEADACHE (severe headache that comes and goes), ARTHRALGIA (joint pain) and FATIGUE (Tiredness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment: Tylenol, Aleve and nausea medication
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Headache, Illness, Nausea
Clinical narrative: extremely weak; nausea; severe headache that comes and goes; joint pain; Tiredness; dizzy; very sick, and . Also has and . Onff c and oough; very sick, and . Also has and . Onff c and oough; no appetite; could not taste anything; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizzy), ILLNESS (very sick, and . Also has and . Onff c and oough), COUGH (very sick, and . Also has and . Onff c and oough), DECREASED APPETITE (no appetite) and AGEUSIA (could not taste anything) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included LISINOPRIL for an unknown indication.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Mar-2021, the patient experienced DIZZINESS (dizzy), ILLNESS (very sick, and . Also has and . Onff c and oough), COUGH (very sick, and . Also has and . Onff c and oough), DECREASED APPETITE (no appetite), AGEUSIA (could not taste anything), ASTHENIA (extremely weak), NAUSEA (nausea), HEADACHE (severe headache that comes and goes), ARTHRALGIA (joint pain) and FATIGUE (Tiredness). The patient was treated with PARACETAMOL (TYLENOL) for Headache and Joint pain, at an unspecified dose and frequency and NAPROXEN SODIUM (ALEVE) at an unspecified dose and frequency. At the time of the report, DIZZINESS (dizzy), ILLNESS (very sick, and . Also has and . Onff c and oough), COUGH (very sick, and . Also has and . Onff c and oough), DECREASED APPETITE (no appetite), AGEUSIA (could not taste anything), ASTHENIA (extremely weak), NAUSEA (nausea), HEADACHE (severe headache that comes and goes), ARTHRALGIA (joint pain) and FATIGUE (Tiredness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment: Tylenol, Aleve and nausea medication